Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The value of artificial intelligence for the treatment of mechanically ventilated intensive care unit patients: An early health technology assessment
7
Zitationen
7
Autoren
2024
Jahr
Abstract
Using the proposed generic health-economic model, investors and innovators can easily assess whether implementing a certain AI system is likely to be cost-effective before an exact clinical impact is determined. The results of the early HTA can aid investors and innovators in deployment of AI systems by supporting development decisions, informing value-based pricing, clinical trial design, and selection of target patient groups.
Ähnliche Arbeiten
Meta-analysis in clinical trials
1986 · 38.884 Zit.
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
2018 · 37.925 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 37.642 Zit.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
2011 · 33.662 Zit.
RoB 2: a revised tool for assessing risk of bias in randomised trials
2019 · 28.906 Zit.